The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

126 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of Potent and Selective Antagonists for the UTP-Activated P2YEBI
University of Bonn
Evaluation of bisbenzamidines as inhibitors for matriptase-2.EBI
University of Bonn
Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila.EBI
University of Bonn
Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors.EBI
University of Bonn
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2).EBI
University of Bonn
Cathepsin B Inhibitors: Combining Dipeptide Nitriles with an Occluding Loop Recognition Element by Click Chemistry.EBI
University of Bonn
Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1).EBI
University of Bonn
HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2).EBI
University of Bonn
Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.EBI
University of Bonn
Novel insights into structure and function of factor XIIIa-inhibitor tridegin.EBI
University of Bonn
3-Cyano-3-aza-ß-amino Acid Derivatives as Inhibitors of Human Cysteine Cathepsins.EBI
University of Bonn
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.EBI
University of Bonn
Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors.EBI
University of Bonn
Carbamazepine derivatives with P2X4 receptor-blocking activity.EBI
University of Bonn
Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).EBI
University of Bonn
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.EBI
University of Bonn
6-Bromo-8-(4-[(3)H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic Acid: a powerful tool for studying orphan G protein-coupled receptor GPR35.EBI
University of Bonn
Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2.EBI
University of Bonn
8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.EBI
University of Bonn
Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.EBI
University of Bonn
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.EBI
University of Bonn
Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.EBI
University of Bonn
Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency.EBI
University of Bonn
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.EBI
University of Bonn
Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2).EBI
University of Bonn
New functional assay of P-glycoprotein activity using Hoechst 33342.EBI
University of Bonn
Fluorescent nitrile-based inhibitors of cysteine cathepsins.EBI
University of Bonn
N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.EBI
University of Bonn
7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists.EBI
University of Bonn
Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.EBI
University of Bonn
4-Substituted-2-phenylquinazolines as inhibitors of BCRP.EBI
University of Bonn
Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F.EBI
University of Bonn
Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.EBI
University of Bonn
Structural optimization of azadipeptide nitriles strongly increases association rates and allows the development of selective cathepsin inhibitors.EBI
University of Bonn
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.EBI
University of Bonn
Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.EBI
University of Bonn
Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.EBI
University of Bonn
Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.EBI
University of Bonn
High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.EBI
University of Bonn
Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.EBI
University of Bonn
A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteins.EBI
University of Bonn
Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.EBI
University of Bonn
Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.EBI
University of Bonn
Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists.EBI
University of Bonn
First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.EBI
University of Bonn
Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors.EBI
University of Bonn
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.EBI
University of Bonn
Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.EBI
University of Bonn
Development of spin-labeled probes for adenosine receptors.EBI
University of Bonn
Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative.EBI
University of Bonn
Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.EBI
University of Bonn
7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: a new heterocyclic system and a new lead compound for dopamine receptor antagonists.EBI
University of Bonn
Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors.EBI
University of Bonn
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein.EBI
University of Bonn
HLE-inhibitory alkaloids with a polyketide skeleton from the marine-derived fungus Coniothyrium cereale.EBI
University of Bonn
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.EBI
University of Bonn
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).EBI
University of Bonn
Identification of the first low-molecular-weight inhibitors of matriptase-2.EBI
University of Bonn
Novel lead for potent inhibitors of breast cancer resistance protein (BCRP).EBI
University of Bonn
Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.EBI
University of Bonn
Monodictyochromes A and B, Dimeric Xanthone Derivatives from the Marine Algicolous Fungus Monodictys putredinis.EBI
University of Bonn
Aromatic 2-(thio)ureidocarboxylic acids as a new family of modulators of multidrug resistance-associated protein 1: synthesis, biological evaluation, and structure-activity relationships.EBI
University of Bonn
Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors.EBI
University of Bonn
Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-stage antiplasmodial activity.EBI
University of Bonn
Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity.EBI
University of Bonn
Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives.EBI
University of Bonn
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs.EBI
University of Bonn
Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity.EBI
University of Bonn
Targeted Protein Degradation of Histone Deacetylases by Hydrophobically Tagged Inhibitors.EBI
University of Bonn
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs.EBI
University of Bonn
Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase EBI
University of Bonn
Expanding the Structural Diversity at the Phenylene Core of Ligands for the von Hippel-Lindau E3 Ubiquitin Ligase: Development of Highly Potent Hypoxia-Inducible Factor-1α Stabilizers.EBI
University of Bonn
Potential cancer chemopreventive in vitro activities of monomeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis.EBI
University of Bonn
Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.EBI
University of Bonn
Bicyclic Peptide Library Screening for the Identification of Gαi Protein Modulators.EBI
University of Bonn
9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein.EBI
University of Bonn
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery.EBI
University of Bonn
Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity.EBI
University of Bonn
A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists.EBI
University of Bonn
Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.EBI
University of Bonn
Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors.EBI
University of Bonn
Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.EBI
University of Bonn
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia.EBI
University of Bonn
Feature-Based Molecular Networking for the Targeted Identification of GEBI
University of Bonn
Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27.EBI
University of Bonn
Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.EBI
University of Bonn
C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors.EBI
University of Bonn
Fluorescent Probes for Ecto-5'-nucleotidase (CD73).EBI
University of Bonn
Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.EBI
University of Bonn
N-Sulfonyl dipeptide nitriles as inhibitors of human cathepsin S: In silico design, synthesis and biochemical characterization.EBI
University of Bonn
Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2YEBI
University of Bonn
1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.EBI
University of Bonn
Substituted 4-phenylthiazoles: Development of potent and selective AEBI
University of Bonn
Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.EBI
University of Bonn
Synthesis and Investigation of Tetrahydro-β-carboline Derivatives as Inhibitors of the Breast Cancer Resistance Protein (ABCG2).EBI
University of Bonn
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.EBI
University of Bonn
Focused screening to identify new adenosine kinase inhibitors.EBI
University of Bonn
Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2).EBI
University of Bonn
Inhibitors of Melanogenesis: An Updated Review.EBI
University of Bonn
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.EBI
University of Bonn
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.EBI
University of Bonn
Bisquaternary ligands of the common allosteric site of M2 acetylcholine receptors: search for the minimum essential distances between the pharmacophoric elements.EBI
University of Bonn
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.EBI
University of Bonn
Cathepsin B: Active site mapping with peptidic substrates and inhibitors.EBI
University of Bonn
Synthesis and biological evaluation of quinazoline derivatives - A SAR study of novel inhibitors of ABCG2.EBI
University of Bonn
Alkynyl-coumarinyl ethers as MAO-B inhibitors.EBI
University of Bonn
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs.EBI
University of Bonn
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.EBI
University of Bonn
Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.EBI
University of Bonn
Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity.EBI
University of Bonn
Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.EBI
University of Bonn
New iantherans from the marine sponge Ianthella quadrangulata: novel agonists of the P2Y(11) receptor.EBI
University of Bonn
Elevation of ligand binding to muscarinic M(2) acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators.EBI
University of Bonn
A BODIPY-Tagged Phosphono Peptide as Activity-Based Probe for Human Leukocyte Elastase.EBI
University of Bonn
Fluorescent-Labeled Selective Adenosine AEBI
University of Bonn
Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.EBI
University of Bonn
2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2.EBI
University of Bonn
Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2).EBI
University of Bonn
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold.EBI
University of Bonn
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2YEBI
University of Bonn
4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2).EBI
University of Bonn
Diindolylmethane Derivatives: Potent Agonists of the Immunostimulatory Orphan G Protein-Coupled Receptor GPR84.EBI
University of Bonn
Thiazolidinone compounds and use thereofBDB
National Health Research Institute
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancerBDB
University of Pittsburgh
Serotonin receptor modulatorsBDB
Janssen Pharmaceutica
Serine/threonine kinase inhibitorsBDB
Array Biopharma